DECORTI, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 15.095
EU - Europa 7.553
AS - Asia 1.703
AF - Africa 71
SA - Sud America 47
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 9
Totale 24.501
Nazione #
US - Stati Uniti d'America 15.064
PL - Polonia 2.427
IT - Italia 1.389
SE - Svezia 1.253
UA - Ucraina 943
CN - Cina 729
HK - Hong Kong 500
FI - Finlandia 332
DE - Germania 263
TR - Turchia 243
IE - Irlanda 217
BG - Bulgaria 216
GB - Regno Unito 147
FR - Francia 80
BE - Belgio 75
SN - Senegal 51
CH - Svizzera 42
IN - India 38
VN - Vietnam 38
SG - Singapore 36
CZ - Repubblica Ceca 32
BR - Brasile 30
KR - Corea 30
NL - Olanda 29
CA - Canada 26
RU - Federazione Russa 24
JP - Giappone 23
AU - Australia 21
AE - Emirati Arabi Uniti 12
PK - Pakistan 12
AT - Austria 11
ES - Italia 11
SI - Slovenia 10
AR - Argentina 8
CL - Cile 8
DK - Danimarca 8
EU - Europa 8
RO - Romania 8
EG - Egitto 7
MY - Malesia 7
NG - Nigeria 6
NO - Norvegia 6
PT - Portogallo 6
RS - Serbia 6
TH - Thailandia 6
HU - Ungheria 5
ID - Indonesia 4
IL - Israele 4
MD - Moldavia 4
TN - Tunisia 4
IR - Iran 3
JO - Giordania 3
PH - Filippine 3
AL - Albania 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
IQ - Iraq 2
LK - Sri Lanka 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CU - Cuba 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LU - Lussemburgo 1
MN - Mongolia 1
PE - Perù 1
TW - Taiwan 1
Totale 24.501
Città #
Warsaw 2.418
Woodbridge 2.164
Ann Arbor 1.849
Fairfield 1.848
Houston 1.332
Chandler 1.315
Ashburn 1.042
Wilmington 886
Jacksonville 849
Seattle 809
Cambridge 590
Trieste 561
Hong Kong 493
Princeton 392
Beijing 226
Izmir 226
Sofia 216
Dublin 211
Dearborn 131
Boardman 122
San Diego 91
Brussels 75
Milan 61
Helsinki 57
Dakar 51
Des Moines 48
Munich 48
Falls Church 42
Hefei 42
Dong Ket 36
Bern 34
Bremen 32
Brno 32
Nanjing 32
Redwood City 32
Düsseldorf 30
Shanghai 30
Buffalo 28
Chicago 27
Jinan 27
Washington 26
Seoul 25
Kunming 23
Norwalk 23
Phoenix 23
Shenyang 23
Redmond 22
Guangzhou 21
Fremont 19
Pune 19
Verona 16
Fano 15
Los Angeles 15
Mestre 15
Nanchang 15
Rome 15
Amsterdam 13
Columbus 13
Chengdu 12
Dallas 12
Detroit 12
São Paulo 12
Taiyuan 12
Fuzhou 11
London 11
Vienna 11
Dubai 10
Kocaeli 10
New York 10
Pignone 10
Sydney 10
Udine 10
Zhengzhou 10
Changsha 9
Edinburgh 9
Hebei 9
Singapore 9
Tokyo 9
Toronto 9
Bologna 8
Taizhou 8
Clearwater 7
Tappahannock 7
Americana 6
Hangzhou 6
Islamabad 6
Menlo Park 6
Paris 6
Tianjin 6
Wuhan 6
Ariano Irpino 5
Auburn Hills 5
Bangkok 5
Boulder 5
Budapest 5
Dongguan 5
Grafing 5
Haikou 5
Ljubljana 5
Madrid 5
Totale 19.215
Nome #
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 366
Pharmacogenetics of thiopurines 363
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 354
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 345
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 341
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 337
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 337
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 336
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 319
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 315
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 287
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 247
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 245
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 242
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 209
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 203
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 196
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 191
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 189
Pharmacogenetics of treatments for inflammatory bowel disease 186
Hemolytic Effects of Water-Soluble Fullerene Derivatives 179
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 174
Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability 172
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 171
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 171
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 170
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 170
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 169
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 169
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 167
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 167
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 166
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 166
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 166
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 166
Personalized therapies in pediatric inflammatory and autoimmune diseases. 162
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 162
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 161
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 158
Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. 157
Selective resistance to different glucocorticoids in severe autoimmune disorders 156
Visualization of adriamycin uptake and internalization by receptor-mediated endocytosis in mast cells. An ultrastructural study using adriamycin-colloidal gold complexes. 156
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 155
The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. 153
Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. 152
SERS of cells: What can we learn from cell lysates? 152
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 151
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 150
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 150
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 147
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 146
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide 145
Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. 144
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 144
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 143
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 143
Toxicity of Hypericum perforatum (St. John's wort) administered during pregnancy and lactation in rats 143
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 140
Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. 140
Amelioration of 4'-Epidoxorubicin-induced cardiotoxicity by sodium cromoglycate. 140
Adriamycin binds to the matrix of secretory granules during mast cell exocytosis. 140
Effect of neomycin and other aminoglycosides on adriamycin uptake in rat peritoneal mast cells. 140
Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. 140
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 139
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 138
Effect of ketotifen on adriamycin toxicity: role of histamine. 138
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 136
Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors 135
Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells 134
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 134
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence 133
Interaction of adriamycin with rat and mouse mast cells: histamine release and cellular uptake. 133
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 133
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease. 132
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 132
Anticonvulsant activity of two polyethylene glycols in mice. 131
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 131
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 131
Characterization of histamine secretion induced by anthracyclines in rat peritoneal mast cells. 130
Glucocorticoids in Pediatric Gastrointestinal Disorders 130
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 130
Letter: TPMT activity and age in IBD patients. 129
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 129
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 127
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 127
Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy. 127
Impairment of motor coordination induced by Doxorubicin in mice. 127
Role of ABC transporters in the BeWo trophoblast cell line. 127
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 127
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 126
Effects of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia. 126
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 126
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 125
Dimethyl sulfoxide inhibits histamine release induced by various chemicals. 124
Adriamycin-induced histamine release from heart tissue in vitro. 123
Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. 123
Effect of polyethylene glycol 400 on adriamycin induced histamine release. 122
Effects of ICRF 159 on adriamycin-induced cardiomyopathy in rats. 122
Binding of aminoglycoside antibiotics by degranulating mast cells. 122
Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo. 122
Totale 17.102
Categoria #
all - tutte 58.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.694 0 0 0 0 0 0 0 0 0 325 896 473
2019/20205.550 287 270 286 977 387 681 672 610 500 306 359 215
2020/20213.773 331 243 318 439 374 409 326 272 213 395 144 309
2021/20222.595 124 158 123 243 56 225 186 104 299 277 160 640
2022/20233.860 372 559 271 571 369 647 32 318 425 57 162 77
2023/20241.997 128 170 109 139 257 198 451 467 40 38 0 0
Totale 25.393